Geschäft · 28.10.20261 Min. Lesezeit
GSK shares dive as weaker sales and mounting costs unnerve investors
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker…